Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.95B
Enterprise Value4.54B
P/E Ratio-10.22
PEG Ratio-0.38
Price/Sales Ratio3.98
Price/Book Ratio1.83
Enterprise/Revenue4.81
Enterprise/EBITDA-21.62

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.39
Operating Margin-0.41
AD

Management Effectiveness

Return On Assets-0.1
Return On Equity-0.17

Income Statement

Revenue789.42M
Revenue/Share2.57
Gross Profit297.81M
EBITDA-183.87M
Net Income-339.63M
Diluted EPS-1.07

Balance Sheet

Total Cash488M
Total Cash/Share1.54
Total Debt1.07B
Total Debt/Equity0.6
Current Ratio0.88
Book Value Per Share5.59

Price History

52-Week Change-24.87
52-Week High17.46
52-Week Low9.45
Moving Average 50 Days10.84
Moving Average 200 Days12.43

Statistics

Average Volume5.45M
Shares Outstanding316.35M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield1.95
Payout Ratio-0.27
Last Split Factor3:2
Last Split DateJune 13, 2018
AD